Speaker(s): 

Angela Schreck, RRT-NPS, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the function and indications for HFOV 3100A in the neonatal population
• Explain the difference between PPHN and MAS and treatment differences for each disease when using the HFOV 3100A in the neonatal population
• Describe the ABG and CXR interpretation based on PPHN and MAS and how to manage a patient correctly when transitioning from conventional to HFOV ventilation
• Recognize the indications for using HFJV over HFOV and the differences between the two
• Describe the settings for HFJV and how to adequately apply and use in a neonatal patient
• Indications for usage of conventional settings when using HFJV and describe what they can be used to help with

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Dr. Ronald Wong, MD, Katie Ritz, BS, RRT-NPS, Mark Williams, RN, Katelyn Green have no identified disclosures. 

CE Committe Member/ Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure:

This presentation/content is HIPPA complaint. 

Commerical Support for this Session.

None.